标题: Substrate specificity of the human renal sodium dicarboxylate cotransporter, hNa [打印本页] 作者: 轻羽 时间: 2009-4-21 13:03 标题: Substrate specificity of the human renal sodium dicarboxylate cotransporter, hNa
Zentrum Physiologie und Pathophysiologie, Abt. Vegetative Physiologie und Pathophysiologie, Georg-August-Universitt Gttingen, Gttingen, Germany ' J2 ?2 q9 X0 g/ R. ~; u/ n# b4 E# F; }" H+ X; {
ABSTRACT; ?4 ]' E4 p0 {$ y/ K* x. |
1 Z: G$ _/ |; W9 v( E1 N: ^: \
Proximal tubule cells extract dicarboxylates from filtrate and blood, using cotransporters located in the brush border [sodium dicarboxylate cotransporter (NaDC-1)] and basolateral cell membrane (NaDC-3). We expressed the human NaDC-3 (hNaDC-3) in Xenopus laevis oocytes and characterized it by the two-electrode voltage-clamp technique. At –60 mV, succinate (4 carbons) and glutarate (5 carbons) generated inward currents due to translocation of three sodium ions and one divalent dicarboxylate, whereas oxalate (2 carbons) and malonate (3 carbons) did not. The cis-dicarboxylate maleate produced currents smaller in magnitude, whereas the trans-dicarboxylate fumarate generated currents similar to succinate. The substituted succinate derivatives, malate, 2,2- and 2,3-dimethylsuccinate, and 2,3-dimercaptosuccinate elicited inward currents, whereas aspartate and guanidinosuccinate showed hardly detectable currents. The C-5 dicarboxylates glutarate and -ketoglutarate produced larger currents than succinate; glutamate and folate failed to cause inward currents. Kinetic analysis revealed, at –60 mV, K0.5 values of 25 ± 12 μM for succinate and 45 ± 13 μM for -ketoglutarate, values close to the plasma concentration of these compounds. For both compounds, the K0.5 was independent of voltage, whereas the maximal current increased with hyperpolarization. As opposed to the rat and flounder orthologs, hNaDC-3 was hardly inhibited by lithium concentrations up to 5 mM. In the absence of sodium, however, lithium can mediate succinate-dependent currents. The narrow substrate specificity prevents interaction of drugs with dicarboxylate-like structure with hNaDC-3 and ensures sufficient support of the proximal tubule cells with -ketoglutarate for anion secretion via organic anion transporter 1 or 3., [) O8 L: D& v }2 a! E
5 Q/ d# ~2 _* d" L1 u-ketoglutarate; folate; kidney; tricarboxylic acid cycle intermediates; lithium sensitivity; succinate + E$ W; k. K- S; S# U' @ 6 Y$ n) `1 {' }+ L$ S1 rKIDNEY PROXIMAL TUBULE CELLS are involved in the uptake and metabolism of tricarboxylic acid cycle intermediates, which include a variety of di- and tricarboxylates such as succinate, citrate, and -ketoglutarate. In the proximal tubule epithelium, the di- and tricarboxylates are taken up from both the luminal and the basolateral side through sodium-coupled transport systems, thereby allowing maintenance of intracellular concentrations of dicarboxylates three- to fourfold higher than those in the plasma (7, 11, 14, 15, 26). + A7 R/ n- O) S/ e7 G* Y ; e; T; ~8 B6 m, i2 tIn conjunction with the organic anion transporters 1 and 3 (OAT1, OAT3; for reviews, see Refs. 2, 7, 26), sodium dicarboxylate cotransporter (NaDC-3) indirectly drives the secretion of a variety of endogenous and exogenous organic anions. By Na -coupled uptake, NaDC-3 provides roughly half of the intracellular -ketoglutarate used for organic anion/dicarboxylate exchange through OAT1 and OAT3 (7). 5 x; H0 S, Z5 y) z' N: j( f 7 g% z) y0 T3 g s0 fIn recent years, the luminal as well as basolateral dicarboxylate transporters from different species including humans have been cloned (for reviews, see Refs. 11, 14, 15) and designated as NaC1 or the aliases NaDC-1 and SDCT1, and NaC2 or the aliases NaDC-3 and SDCT2 (for a review, see Ref. 11). NaDC-1 was localized to the luminal membrane as demonstrated by Western blot analysis using luminal membrane fractions and a polyclonal antibody directed against a 60-amino-acid peptide from NaDC-1 (19). Basolateral localization of human (h) NaDC-3 was by a polyclonal antibody raised against the fusion protein of glutathione S-transferase (GST)-hNaDC-3 (25).- X! y" [9 l8 ?3 Z
5 |9 K# Z! O5 e, h, ^
Functional characterization of heterologously expressed transporters has been primarily performed in human retinal pigment epithelial cells or Xenopus laevis oocytes using radiotracer flux or two-electrode voltage-clamp techniques (for reviews, see Refs. 11, 14, 15). These experiments confirmed the results obtained in the intact rat kidney, isolated, perfused tubules, and vesicles from either luminal or basolateral membranes and revealed that all members perform Na -coupled cotransport of various tricarboxylic acid cycle intermediates. The stoichiometry of sodium-anion symport is 3:1. The coupling of three Na to one generally divalent anion renders the symport electrogenic, with a net transfer of one positive charge across the cell membrane. Transport is thought to be ordered with sodium binding to the transporter before the anion, and lithium can act as a competitive inhibitor to sodium.4 [) \ ]* p* E3 p) B: A2 U# m
' {, L+ L' r; R8 L' R. l: W$ g
As tested with various NaDC-1 orthologs, NaDC-1 has a substrate preference for succinate (K0.5 0.18–1.1 mM) and citrate (K0.5 0.32–6.8 mM). Significant cis-inhibition of radiolabeled succinate uptake was observed in decreasing potency with succinate, fumarate, malate, oxaloacetate, and citrate. Substrate-associated currents were measured with succinate, -ketoglutarate, glutarate, oxaloacetate, fumarate, and malate (11, 14, 15). NaDC-3 prefers 2,2-dimethylsuccinate over succinate and cis-inhibition of succinate uptake was demonstrated with 2,2- and 2,3-dimethylsuccinate, succinate, glutarate, -ketoglutarate, fumarate, citrate, malonate, glutamate, maleate, and pyruvate. Significant currents (>20% of control) were evoked by -ketoglutarate, fumarate, malate, succinate, and the dimethylsuccinates. ! {: C+ e8 E" n3 r 4 y% k' g. q8 Y" v5 v r PDespite many similarities, NaDCs show species differences. Rat renal NaDC-1 (SDCT1, rNaC1), located in the brush-border membrane, has a much higher affinity for succinate (5) than the orthologs from rabbit and human kidneys (18). Moreover, lithium only slightly inhibited human NaDC-1 (18) but strongly decreased transport by NaDC-1 and NaDC-3 from other species (5, 6, 17, 24). Although lithium is used for treatment of bimodal disorders in humans (21), it is not known whether hNaDC-3 and, hence, the supply of proximal tubular cells with dicarboxylates for metabolism and organic anion secretion are impaired at pharmacological lithium concentrations. Finally, endogenous derivatives of dicarboxylates, like folate, guanidinosuccinate, and quinolinate, have not yet been tested as putative substrates of NaDC-3. In uremic patients, guanidinosuccinate and quinolinate concentrations in plasma are increased (23) with possible side effects in renal dicarboxylate transport.! L: |; [; ] G9 C
7 p" a3 t1 @/ pThe aim of the present study was to determine the specificity of human NaDC-3 for di- and tricarboxylates and its interaction with lithium. 7 h/ [7 H6 q5 q+ y A; S1 R- ~0 J: z7 _0 X: h9 }# f
MATERIALS AND METHODS o: [. @5 ]; u4 Z, c3 }1 S% ]" {6 i! D! j8 M
In vitro transcription of cRNA. Sodium-dependent dicarboxylate transporter NaDC-3 cDNAs from human (24) kidney were used as a template for cRNA synthesis. Plasmids were linearized with NotI, and in vitro cRNA transcription was performed using T7 mMessage mMaschine Kit (Ambion, Austin, TX). The resulting cRNA was suspended in purified, RNAse-free water to a final concentration of 1 μg/μl. ^1 z, C- t" n# k8 ? x
9 i8 l4 M ^( `0 O! g! r) b% v5 R
Oocyte preparation and storage. Stage V and VI oocytes from X. laevis (Nasco, Fort Atkinson, WI) were separated by treatment with collagenase (Typ CLS II, Biochrom, Berlin, Germany) and maintained afterwards at 16–18°C in control solution (in mM): 110 NaCl, 3 KCl, 2 CaCl2, 5 HEPES/Tris, pH 7.5. One day after removal from the frog, oocytes were injected with 30 nl of cRNA coding for hNaDC-3 and maintained at 16–18°C in control solution supplemented with 50 μM gentamycin and 2.5 mM pyruvate. After 3 to 4 days of incubation with daily medium changes, oocytes were used for electrophysiological studies. Oocytes injected with water served as controls.: P A1 Z& [4 b) |
) q! w g% b5 C J w4 X0 eElectrophysiological studies. Electrophysiological studies were performed by the conventional two-microelectrode voltage-clamp method (3, 4). Oocytes were superfused with control solution and after stabilization of the membrane potential, single oocytes were clamped at –60 mV and the current induced by 1 mM succinate was measured to demonstrate functional expression of the hNaDC-3 protein. Voltage pulses between –90 and 10 mV, in 10-mV increments, were applied for 5 s each and steady-state currents were recorded to obtain current-voltage (I-V) relationships. In general, the I-V protocol was applied first under control conditions and then 30 s after changing the superfusion to the test solution. The difference between the steady-state currents measured in the presence and absence of substrates was considered as substrate-induced current, I. Water-injected controls showed no substrate-dependent currents in response to mono-, di-, and tricarboxylates.2 ]. m7 k$ V" i' _) E1 P O ~3 S7 o
' p5 F# u, c9 z( ^Chemicals. All chemicals were purchased from Sigma (Taufkirchen, Germany) or Merck (Darmstadt, Germany). Control solution was prepared as a five times concentrated stock solution. Appropriate dilution and addition of the test substrate were performed at the day of the experiment. Sodium-free solutions were obtained either by equimolar substitution of all sodium by N-methyl-D-glucamine or lithium. / j7 Y, `: H4 v9 C . t; N8 f" J0 m& n$ ], E/ ? v8 bRESULTS0 O: J8 L4 A3 y1 D8 k" M
) n# B; I- L( E' r3 W" EInteractions of lithium with hNaDC-3. Application of succinate (1 mM) to hNaDC-3-expressing oocytes yielded potential-dependent inward currents that were larger in amplitude at negative than at positive clamp potentials (Fig. 1A, ). These succinate-associated currents were, in contrast to succinate-induced currents observed in oocytes expressing rat or mouse NaDC-3, only marginally affected by increasing lithium concentrations. As measured in paired experiments in five oocytes from three donors, in the absence of lithium, currents induced by 1 mM succinate were –56 ± 6, –44 ± 5, –32 ± 4, and –22 ± 3 nA at –90, –60, –30, and 0 mV, respectively (Fig. 1A, ). These currents only slightly decreased in response to increasing concentrations of lithium. In the presence of 5 mM lithium, succinate-induced currents decreased to –41 ± 5, –32 ± 4, –26 ± 3, and –18 ± 3 nA (Fig. 1A, ). When at a holding potential of –90, –60, and –30 mV (Fig. 1B), the succinate-induced currents were plotted as a function of increasing lithium concentrations, residual lithium-insensitive currents of 73, 72, 81, and 81% of the initial current persisted. & Q$ X; ^8 W. a+ q# e0 p* z# n: m8 K" ^
Total replacement of sodium by lithium, as performed in paired studies with four hNaDC-3-expressing oocytes from four donors, revealed the following results. In the presence of sodium, steady-state currents showed in the absence (Fig. 2A, ) and presence (1 mM, Fig. 2A, ) of succinate near-to-linear I-V relationships throughout the tested potential range. Succinate-induced currents (Fig. 2C, ) were inwardly directed within the potential range between –90 and 0 mV, in support of the proposed coupling of three sodium ions for each divalent succinate. When all sodium was replaced by lithium (Fig. 2B), steady-state currents in the absence (Fig. 2B, ) and presence of succinate (1 mM, Fig. 2B, ) showed again near-to-linear I-V relationships. The succinate-associated currents (Fig. 2C, ), however, differed markedly from those obtained in the presence of sodium. These currents increased in amplitude as the potential depolarized (Fig. 2C, ). For comparison, the succinate-induced currents in the presence of sodium decreased from –44 ± 5 nA at –90 mV to –30 ± 7 nA at –30 mV (Fig. 2C, ) and changed in the presence of lithium from 3 ± 2 nA at –90 mV to –7 ± 2 nA at –30 mV (Fig. 2C, ). When all sodium was replaced by N-methyl-D-glucamine, succinate-induced currents were completely abolished (data not shown). 3 W2 J+ K4 @+ \) T# x* A* P0 o9 E. _& m% B$ i* T! f/ T
Substrate specificity: Carbon chain length and different substitutions at C-2 and C-3. Citric acid cycle intermediates consist of carboxylates with a chain length of four to six carbons connected either by single or double bonds and different substitutions at C-2 or C-3. The substrate specificity of tricarboxylic acid cycle intermediates irrespective whether they are mono-, di-, or tricarboxylates at physiological pH was tested by measuring currents induced by these compounds at a holding potential of –60 mV (Fig. 3). The data are expressed as a percentage of the succinate-induced currents in the same oocytes. The substrate concentration used was 1 mM, which should yield maximal-inducible currents, at least in the case of succinate. Succinate, -ketoglutarate, fumarate, malate, and oxaloacetate produced currents of similar amplitude. Currents of 5 a% [$ f! f$ w. Z 1 h0 c0 b& j( P; n% t# iSuccinate- and -ketoglutarate-induced currents were examined to identify the substrate concentration at half-maximal current (K0.5) for these substrates under voltage-clamp conditions in the range between –90 and 0 mV. Succinate as well as -ketoglutarate showed potential-dependent inward currents that saturated at concentrations >0.5 mM. In the case of succinate, application of higher concentrations decreased substrate-dependent currents (data not shown) most probably due to intracellular accumulation. As determined in four oocytes from three donors, the K0.5 for succinate was 25 μM independent of membrane voltage (Fig. 4A). The succinate-induced maximum current at saturating concentrations (Imax) increased as the membrane voltage was made more negative (Fig. 4B). Similar results regarding K0.5 and Imax were obtained for -ketoglutarate. K0.5 was 35 μM independent of membrane voltage (Fig. 4C), and Imax again increased as the oocytes became hyperpolarized (Fig. 4D, 4 determinations from 3 donors).* @/ N, q- K$ d
' m# Y; e3 N: jThe ratio Imax/K0.5 indicates the transport efficiency of the transporter for a given substrate (Table 1). Imax/K0.5 decreased in the order succinate glutarate > -ketoglutarate, indicating that transport efficiency was not dependent on the length of the carbon backbone, and substitution at C-2 influenced transport efficiency.6 v- N8 Z/ d0 v/ ^0 k) M/ q
5 ^" M: _# z2 h# d0 y) m
View this table:/ h# V, n1 {. J( T4 v4 [9 G
2 p8 y$ Q/ J" R, q8 e) }
In addition to succinate, other C-4 and C-5 dicarboxylates, which are not members of the tricarboxylic acid cycle, were also translocated via hNaDC-3. The data are plotted as percent of the succinate-induced currents in the same oocytes. The introduction of two methyl groups at C-2 (2,2-dimethylsuccinate, 2,2-DMS) increased substrate-dependent current to 152 ± 4% (Fig. 5). However, the substitution at C-2 and C-3 with either methyl-(2,3-dimethylsuccinate), (2,3-DMS) or sulfhydryl-groups (2,3-dimercaptosuccinate, DMSA, succimer) reduced the current to 74.5 ± 5 and 28 ± 7%, respectively, compared with succinate (4 oocytes from 4 frogs). Aspartate and glutamate differ from succinate and glutarate, respectively, by the presence of a positively charged NH3 group at C-2. This substitution decreased aspartate- and glutamate-associated currents to 18 ± 12 and 3 ± 1% of control (3 oocytes from 3 donors). Fumarate and maleate are both C-4 dicarboxylates and differ with respect to the trans- and cis-position of their COOH groups. Fumarate exhibited currents comparable in magnitude to succinate (see Fig 3), whereas maleate induced barely detectable currents (Fig. 5)./ J7 ]4 |2 |/ R
* j; ^+ ]; Y$ s4 kDivalent dicarboxylates with shorter chain lengths like oxalate (C-2) and malonate (C-3) showed no substrate-induced currents ( 4 |6 j' z: I3 P- C0 s1 T/ U: F- I8 x% `, i @
Interactions of other dicarboxylates and related compounds that may be substrates of hNaDC-3: Folate, quinolinate, and guanodinosuccinate. As shown in Fig. 6A, folate, formally an N-substituted glutamate derivative with two COOH groups, seemed not to be a substrate of hNaDC-3. At –60 mV in paired experiments with four oocytes from four donors, succinate (1 mM, Fig. 6A, ) induced an inward current of –26 ± 1 nA, whereas the folate-associated current was –1 ± 1 nA (Fig. 6A, ). Folate concentrations up to 10 mM did not induce substrate-dependent currents (data not shown). Folate, however, was able to alter succinate-induced currents. Compared with succinate (1 mM, Fig. 6B, ), simultaneous application of succinate (1 mM) and folate (0.5 mM, Fig. 6B, ) resulted in small inward currents at potentials more negative than –60 mV and outward currents were seen at potentials more positive than –60 mV (paired experiments with 4 oocytes from 4 donors). 8 e9 r+ J- J2 S+ m( R( L) z5 y6 A5 e1 h) w$ k
Quinolinate, a cyclic dicarboxylate derived from trypthophan metabolism, showed compared with succinate (Fig. 7A, ) small potential-dependent inward currents (Fig. 7A, ). However, whereas the succinate-evoked currents reversed at positive potentials, the quinolinate-induced currents reversed at –36 ± 15 mV. Picolinate (1 mM), a cyclic monocarboxylate, did not induce currents at all (Fig. 7A, ). These experiments were performed with eight oocytes from three donors. In addition, quinolinate (0.5 mM) was not able to inhibit the currents elicited by succinate. As determined in seven oocytes from three donors, the currents measured in the simultaneous presence of succinate (1 mM) and quinolinate (0.5 mM; Fig. 7B) were not significantly different from those induced by succinate alone (1 mM, Fig. 7B, ).% N. g. X7 y9 F* K: z
. F. G0 x2 e+ }Guanidinosuccinate is a toxin present in uremic plasma up to concentrations of 0.35 mM (23). As observed in paired experiments on nine oocytes from seven donors, at –60 mV the currents induced by 1 mM (Fig. 8A, ) and 10 mM guanidinosuccinate () were –1 ± 1 and –3 ± 1 nA, respectively, whereas the succinate-induced current () reached –33 ± 15 nA. Guanidinosuccinate was able to inhibit to some extent the succinate-evoked current (Fig. 8B, ). At –60 mV and in paired experiments in seven oocytes from three donors, the current determined in the simultaneous presence of guanidinosuccinate (0.5 mM) and succinate (1 mM) was 76.9 ± 15.1% of the current produced by succinate (1 mM) alone.( s$ ?5 P: c# y0 Z* M M* s- `0 w
$ T9 @) N. ?) ? x
DISCUSSION% Z3 `) a+ x6 H6 w5 \+ I' X! G
4 l- I/ S, d& a/ BMammalian NaDCs are plasma membrane transporters mediating the cellular entry of a variety of dicarboxylates that are intermediates in the tricarboxylic acid cycle (e.g., succinate, fumarate, malate, and -ketoglutarate) in an electrogenic sodium-dependent fashion (11, 14, 15). Accordingly, the transport can be visualized by cell membrane depolarization, and, under voltage-clamp conditions, by an inward current. Succinate-induced currents were a linear function of the holding potential, being smaller at less negative potentials and reversing at positive potentials. This behavior is in accordance with an electrogenic cotransport of three sodium ions with one dicarboxylate, a property shared by all NaDCs. However, there are significant functional differences between NaDC-1 and NaDC-3 with regard to the cation effect. When sodium was replaced by choline or cesium, substrate-dependent inward currents were abolished in oocytes expressing the rabbit NaDC-1 (17). During substitution of sodium by lithium, however, succinate-induced inward currents were observed (17), which decreased as the membrane depolarized. This indicated that the Li -succinate–2 stoichiometry is most likely 3:1 in rabbit NaDC-1. When these studies were repeated in oocytes expressing hNaDC-1, no such succinate-induced currents were detected in the presence of lithium (27), indicating species differences with respect to the ability of Li to support succinate transport. ( t$ b, K) J, x" w" ]8 J) F: @: t : y! e2 H- S& X" B! A: e, ^) i1 d# {During total replacement of sodium by lithium, succinate induced outward current deflections at holding potentials that changed into inward current deflections at potentials less negative than –50 mV in oocytes expressing mouse NaDC-3 (16) and hNaDC-3 (this study). These currents were much smaller than the inward currents induced by succinate in the presence of sodium. The nature of the current deflections seen in the presence of lithium is unclear. If three Li would be cotransported with succinate, the currents should be inward at all tested potentials, as found for rbNaDC-1 (17). The cotransport of two Li with one succinate would result in an electroneutral process not visible by the two-electrode voltage-clamp technique. In case of cotransport of one Li with one succinate, outward currents increasing with depolarizing membrane potentials should be observed. I-V relationships in the presence of lithium revealed a small decrease in conductance when succinate was added. Therefore, succinate appears to inhibit rather than to induce a current in the presence of lithium. The mechanism of this process remains to be determined.+ N# C+ E# e: N, F6 A3 C/ B
" [ |% Y% q- M6 W
In our experiments on hNaDC-3, up to 5 mM Li only slightly inhibited succinate-induced currents. A comparably small effect of Li was found with hNaDC-1 (18), whereas rodent NaDC-1 and NaDC-3 were strongly inhibited by lithium (6, 10, 17, 18), indicating again species differences. The plasma concentrations of lithium used for the treatment of bimodal disorders are in the range of 0.8–2 mM (21). At these concentrations, neither hNaDC-1 nor hNaDC-3 is inhibited, suggesting that therapeutic concentrations of lithium do not affect reabsorption of succinate and other dicarboxylates either from the tubular lumen or from the peritubular capillaries. The observed increase in urinary citrate excretion during lithium therapy can, therefore, not be attributed to an effect on NaDC-1 and NaDC-3 and suggests that a distinct transporter for citrate is affected. Such a transporter has not yet been identified in the human kidney. G) W( Q) l8 s% y5 u4 a! G
O5 I C- e- [ S$ bhNaDC-3 has a broad substrate specificity for 4- and 5-carbon, terminal dicarboxylic acids in the trans-configuration, including the tricarboxylic acid cycle intermediates succinate and -ketoglutarate. The kinetic constants for hNaDC-3 as derived from the two-electrode voltage-clamp studies agree quite well with previous data. The K0.5 for succinate was in the range of 30 μM in agreement with the K0.5 of 20 ± 1 μM obtained in human retinal pigment epithelial cells transfected with hNaDC-3 but is lower than the K0.5 of 102 ± 20 μM in hNaDC-3-expressing oocytes (24). In the potential range between –90 and 0 mV, the K0.5 for succinate was not affected by the membrane potential, suggesting that binding of succinate to the transporter is voltage independent. Similar findings were obtained for -ketoglutarate showing a potential-independent K0.5 of 40 μM. Importantly, these K0.5 values are in the range of the circulating plasma concentrations of succinate and -ketoglutarate, which lie between 10 and 40 μM (26). The transport efficiency, Imax/K0.5, for succinate and -ketoglutarate differed by a factor of 2.1 for hNaDC-3. As opposed, succinate was translocated 15 times more efficiently than -ketoglutarate in hNaDC-1 (27), indicating differences in the substrate binding and translocation between hNaDC-1 and hNaDC-3.( Y- g" `( Y7 F0 B
9 @" d' P; |% x7 Y% ?
Besides succinate and -ketoglutarate, hNaDC-3 translocated the dicarboxylic tricarboxylic acid cycle intermediates fumarate, malate, and oxaloacetate, as visualized by the respective substrate-induced currents. With the tricarboxylates citrate, isocitrate, and cis-aconitate, much smaller currents were observed, indicating a considerably slower translocation. At 25°C, the pKs of citrate are 3.1, 4.8, and 6.4, respectively. Therefore, at physiological pH, less than 10% of citrate is present as a divalent anion. This implies that at a total concentration of 1 mM citrate, 0.1 mM citrate–2 was responsible for the observed small inward current. The total plasma concentration of citrate is 0.135 mM (26). At pH 7.4, less than 0.014 mM of citrate is present as a divalent anion, a concentration too low to interact significantly with hNaDC-3. Because citrate is excreted in healthy humans, another transporter responsible for translocation of citrate and presumably other trivalent carboxylates such as isocitrate and cis-aconitate must be present in the kidneys. Similar findings with respect to citrate were observed with hNaDC-1 (27). # l& m4 F, E: d1 f ' i0 x" _" o2 P7 VAmong other carboxylates, the moncarboxylate pyruvate showed small substrate-dependent inward currents. This finding fits with another study, in which uptake of radiolabeled pyruvate into hNaDC-3-expressing oocytes was demonstrated (9). In addition, the monocarboxylate lactate (this study) and the monovalent anion dimercapto-1-propane sulfonate showed inward currents of small amplitude in oocytes expressing either hNaDC-3 or fNaDC-3 (3), demonstrating that the NaDC-3s from different species are able to handle monovalent anions, at least to a small extent./ r! K3 {4 W! W: B0 q& ^" U
i, H, W+ l- v" ^* WhNaDC-3 also interacted with dicarboxylates substituted with two methyl groups (2,2-DMS, 2,3-DMS) or two mercapto groups (2,3-DMSA). 2,2-DMS induced a current larger than that evoked by succinate, whereas 2,3-DMS produced a considerably smaller current. Rat NaDC-3 transported 2,3-DMS with high affinity (K0.5 27.2 ± 2.2 μM), and 2,3-DMS evoked 60% of the succinate-induced current (6). In contrast, rat NaDC-1 showed low affinity for 2,3-DMS (K0.5 272 ± 3 μM) and evoked only 17% of the succinate-evoked current (6). Thus NaDC-1 does not appreciably interact with 2,3-DMS. In a previous study on flounder NaDC-3 (3), we showed that the K0.5 for 2,2-DMS was independent of voltage, whereas the K0.5 for 2,3-DMS increased with decreasing voltage, suggesting that the position of substituents at the succinate molecule determines the voltage dependence of the apparent affinity. The second 2,3-disubstituted compound, DMSA, contains a backbone of four carbons, two negatively charged COOH groups and two vicinal sulfhydryl groups, which are highly active in chelating free heavy metals like lead and mercury within cells or blood (1). Heavy metals are predominantly deposited within renal proximal tubule cells (28). Therefore, renal detoxification requires the entry of uncomplexed DMSA via a transport system (28). In the present study, we provide evidence for the translocation of DMSA by human NaDC-3. Once within the cell, DMSA can chelate heavy metals and thus contribute to detoxification. Thus hNaDC-3 appears to be instrumental for the increased renal heavy metal excretion during administration of DMSA. ) V. e0 L, }& H' j$ {2 Y" [; o9 U, L/ r( q! ~4 U7 ]" t
Folate is freely filtered at the glomerulus and undergoes active reabsorption as well as secretion in the proximal tubule (8, 12). OAT1 (20) and OAT3 (22) can facilitate uptake of folate or folate derivatives like methotrexate across the basolateral membrane. Because folate possesses a 5-C backbone similar to glutarate and glutamate, we investigated its interaction with hNaDC-3. Folate, however, did not induce any current most probably due to its bulky substitution at C-2. However, folate markedly interfered with succinate-induced currents, which were no longer a linear function of the holding potential, and reversed at about –60 mV rather than at positive voltages. Such a change in succinate-induced current was observed earlier with flufenamate and was attributed to the occurrence of a K conductance, the nature of which remained unclear (4). 7 d* n9 B+ i* y; Y0 H4 ]6 Q/ W p% R# T) a & K/ e, O0 L& [: mCirculating uremic toxins have been proposed to facilitate progression of chronic renal failure. The monovalent organic anions indoleacetate, indoxyl sulfate, hippurate, and p-hydroxyhippurate are handled by OAT1 (13). We tested here the dicarboxylic uremic toxins, guanidinosuccinate and quinolinate (23). Neither guanidinosuccinate nor quinolinate was able to induce substrate-dependent currents. Guanidinosuccinate, but not quinolinate, inhibited succinate-induced currents up to 20%. Thus the cyclic dicarboxylate quinolinate is not a substrate of hNaDC-3, whereas guanidinosuccinate may act as an inhibitor in uremia. % C# }( A1 J7 {" X! j! ] Y . f9 D B% g, I: ^ ~Taken together, the human NaDC-3 shows affinities for succinate and -ketoglutarate matching their plasma concentrations. For translocation, C-4 and C-5 dicarboxylates with the COOH groups in trans-configuration are preferred. Substituted dicarboxylates do not induce currents when a positively charged NH2 group is present as in aspartate, glutamate, or guanidinosuccinate or when the substitution is too bulky as in folate. The narrow substrate specificity prevents hNaDC-3 from reacting with anionic drugs and enables it to continuously provide proximal tubule cells with dicarboxylates as fuels and with -ketoglutarate as exchange partner during anionic drug secretion via OAT1 and OAT3. * g) j0 E; x& p" p/ ` + ~0 Z4 f) i9 H1 qGRANTS8 ^, L% }- x& E8 M: q
* |! r9 k- r9 s% B W' r' e8 U, s
This research was supported by Deutsche Forschungsgemeinschaft Bu 998/2–2, 3 to B. C. Burckhardt. - u; n6 M$ G% X! L+ @2 D* e. t$ l 0 a+ W. y; J8 |) u+ O2 a+ BACKNOWLEDGMENTS 1 `7 T$ H9 o- C b( D' ]* k- y" i4 t8 A2 ]
The authors thank V. Ganapathy for the generous gift of the hNaDC-3 clone. The help of I. Markmann and S. Holpert during the course of the experiments and E. Thelen in preparing the figures is gratefully acknowledged.; ]5 j# r0 R$ @9 J; e
5 }- u# o" B2 q1 DFOOTNOTES( P4 t$ Z8 k; o( B O Q
1 w" u2 x+ u) w. e+ W& GThe costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. " K5 q6 E7 N3 k! f4 C: n& ` , `1 @3 m& q6 L6 n5 s, S* EREFERENCES : _. [; \) I6 E+ `& ~3 `* m2 X7 @' j/ l, f: g
Aposhian HV. Meso-2,3-dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu Rev Pharmacol Toxicol 30: 279–306, 1990. " l* \5 p; h2 u7 c7 C1 ` P1 m! V) X4 B! @9 qBurckhardt BC and Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146: 95–158, 2003. 6 O# k. K) E" W7 d0 G3 m: z8 v& Y 6 p i, \% P T0 i, ZBurckhardt BC, Drinkuth B, Menzel C, Knig A, Steffgen J, Wright SH, and Burckhardt G. The renal Na -dependent dicarboxylate transporter, NaDC-3, translocates dimethyl- and disulfhydryl compounds and contributes to renal heavy metal detoxification. J Am Soc Nephrol 12: 2628–2638, 2002. W, ^ D5 B) }( X % \6 I/ f1 @+ T/ \6 hBurckhardt BC, Lorenz J, Burckhardt G, and Steffgen J. Interactions of benzylpenicillin and nonsteroidal anti-inflammatory drugs with the sodium-dependent dicarboxylate transporter NaDC-3. Cell Physiol Biochem 14: 415–424, 2004.9 E* e0 V7 {! J% T
' T c* o7 k5 d) @% L# f& H1 b2 G
Chen XZ, Shayakul C, Berger UV, Tian W, and Hediger MA. Characterization of a rat Na -dicarboxylate cotransporter. J Biol Chem 273: 20972–20981, 1998. 8 Q, a" s4 |# P; t( W& {0 \: g 3 G$ p4 ]3 h" S( d) o5 oChen X, Tsukaguchi H, Chen XZ, Berger UV, and Hediger MA. Molecular and functional analysis of SDCT2, a novel rat sodium-dependent dicarboxylate transporter. J Clin Invest 103: 1159–1168, 1999.; {7 c- r) z7 S6 G, `
# c/ {8 v0 z: `) f7 O. A
Dantzler WH. Renal organic anion transport: a comparative and cellular perspective. Biochim Biophys Acta 1566: 169–181, 2002.7 W' Z) E& l0 x1 S' d# M( C
g8 y) f6 U; s, T. p) Q9 LGorensky CA, Watanabe H, and Johns DG. The renal excretion of folic acid. J Clin Invest 42: 1841–1849, 1963.8 _+ e. Z3 V& k/ M% O. { W) q
. G+ _# Y, q$ }6 M
Inoue K, Fei YJ, Huang W, Zhuang L, Chen Z, and Ganapathy V. Functional identity of Drosophila melanogaster Indy as a cation-independent, electroneutral transporter for tricarboxylic acid-cycle intermediates. Biochem J 367: 313–319, 2002.* P+ C) ^# J) d! y" Z
( u; J( j$ ]3 p( l
Kekuda R, Wang H, Huang W, Pajor AM, Leibach FH, Devoe LD, Prassad PD, and Ganapathy V. Primary structure and functional characteristics of a mammalian sodium-coupled high affinity dicarboxylate transporter. J Biol Chem 274: 3422–3429, 1999. * r4 c. Q5 c. ^6 `4 z' L7 d + {6 a/ z+ c8 F0 n+ L& NMarkovich D and Murer H. The SLC13 gene family of sodium sulphate/carboxylate cotransporters. Pflügers Arch 447: 594–602, 2004. 1 a1 d y! Z+ h2 n3 Z/ e3 \ b& T* q8 C) p! I. A8 T+ Z" z
McMartin KE, Morshed KM, Hazen-Martin DJ, and Sens DA. Folate transport and binding by cultured human proximal tubule cells. Am J Physiol Renal Fluid Electrolyte Physiol 263: F841–F848, 1992. # u( I+ w, e# t6 F+ p" ]# [& O" w 2 J: p0 s5 ^+ SMotojima M, Hosokawa A, Yamato H, Murake T, and Yoshioka T. Uraemic toxins induce proximal tubular injury via organic anion transporter 1-mediated uptake. Br J Pharmacol 135: 555–563, 2002. 4 [! n4 @0 E0 p1 X- D! |7 `$ z, c3 M% ~' s7 U$ ~
Pajor AM. Sodium-coupled transporters for tricarboxylic acid cycle intermediates. Annu Rev Physiol 61: 663–682, 1999. : @5 f7 j7 N# L 5 c8 H$ r8 L$ IPajor AM. Molecular properties of sodium/dicarboxylate cotransporters. J Membr Biol 175: 1–8, 2000. # s. v; ? e0 r2 @. I' e0 P- ~+ ^3 X2 ^* X+ i. Z3 v2 K
Pajor AM, Gangula R, and Yao X. Cloning and functional characterization of a high-affinity Na /dicarboxylate cotransporter from mouse brain. Am J Physiol Cell Physiol 280: C1215–C1223, 2001.; b" x7 F+ H1 r: X& V$ K
* M0 h) o) n- W% l) ?5 o
Pajor AM, Hirayama B, and Loo DDF. Sodium and lithium interactions with the Na /dicarboxylate cotransporter. J Biol Chem 273: 18923–18929, 1998. 8 @9 V a/ v4 D , j4 R$ [8 D+ I& ZPajor AM and Sun N. Functional differences between rabbit and human Na -dicarboxylate cotransporters, NaDC-1 and hNaDC-1. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1093–F1099, 1996.+ j& C) v! I; g! e4 F
) L* L4 v0 q% w9 f
Pajor AM and Sun N. Characterization of the rabbit renal Na -dicarboxylate cotransporter using antifusion protein antibodies. Am J Physiol Cell Physiol 271: C1808–C1816, 1996. i/ L$ E7 s ?8 q, j
9 H; \5 Q* W+ U* U: g4 RSekine T, Watanabe N, Hosoyamada M, Kanai Y, and Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272: 18526–18529, 1997. 6 c: @; L$ U/ f% s# b' a9 C! B* t9 K4 h" H( _* F
Sproule B. Lithium in bipolar disorder. Can drug concentration predict therapeutic effect Clin Pharmacokinet 41: 639–660, 2002. ! K! e) |5 w2 F# f/ I A - H6 V W4 f4 C9 K# yTakeda M, Khamdang S, Narikawa S, Kimura H, Hosoyamada M, Cha SH, Sekine T, and Endou H. Characterization of methotrexate transport and its drug interaction with human organic anion transporters. J Pharmacol Exp Ther 302: 666–671, 2002. 8 Q6 y' [ _) a5 t+ l3 ] % k, D! m$ r; K/ i. Y/ BVanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jrres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, and Zidek W. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int 63: 1934–1943, 2003. $ f% y' i; D0 S$ m) R; n1 N: Q4 h4 ?9 m: j# V8 `1 Z- I
Wang H, Fei YJ, Kekuda R, Yang-Feng TL, Devoe LD, Leibach FH, Prassad PD, and Ganapathy V. Structure, function, and genomic organization of human Na -dependent high-affinity dicarboxylate transporter. Am J Physiol Cell Physiol 278: C1019–C1030, 2000.9 h$ }$ n& J1 e) y' H o Z2 ~
- G7 |# |) p$ s" X9 \! e! r1 F
Wang J, Chen X, Zhu H, Peng L, and Hong Q. Relationship between aging and renal high-affinity sodium-dependent dicarboxylate cotransporter-3 expression characterized with antifusion protein antibody. J Gerontol A Biol Sci Med Sci 58: 879–888, 2003. " L9 p! t% \7 s u9 |. {- H; B. s7 `9 `
Wright SH and Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84: 987–1049, 2004. " z3 b# Y$ V0 \6 |; ]9 c5 G, L6 X : H( y$ z" p9 j: ~Yao X and Pajor AM. The transport properties of the human renal Na -dicarboxylate cotransporter under voltage-clamp conditions. Am J Physiol Renal Physiol 279: F54–F64, 2000.' C! J" W* H W& R* ~' t& ]
# w: c; I: K# W) { l5 n0 lZalups RK. Molecular interactions with mercury in the kidney. Physiol Rev 52: 113–143, 2000.(Birgitta C. Burckhardt, J)作者: 泡泡鱼 时间: 2015-6-3 22:42